Clinical Trial Details
| Trial ID: | L4819 |
| Source ID: | NCT05544214 |
| Associated Drug: | Ckd-371 |
| Title: | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects |
| Acronym: | CKD-371 |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type II Diabetes Mellitus |
| Interventions: | DRUG: CKD-371 |
| Outcome Measures: | Primary: AUCt of CKD-371, D745+D759, Area under the CKD-371, D745+D759 concentration in blood-time curve from zero to final, Pre-dose(0hr), post-dose 0.33, 0.67, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, 24, 48hr|Cmax of CKD-371, D745+D759, The maximum CKD-388/D418 concentration in blood sampling time, Pre-dose(0hr), post-dose 0.33, 0.67, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, 24, 48hr | |
| Sponsor/Collaborators: | Sponsor: Chong Kun Dang Pharmaceutical |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 32 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2022-10-21 |
| Completion Date: | 2022-11-17 |
| Results First Posted: | |
| Last Update Posted: | 2023-03-22 |
| Locations: | Korea University Anam Hospital, Seoul, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT05544214 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|